Researchers map paths to cancer drug resistance
A team of researchers led by Duke Cancer Institute has identified key events that prompt certain cancer cells to develop resistance to otherwise lethal therapies.
Dec 23, 2014
0
0
A team of researchers led by Duke Cancer Institute has identified key events that prompt certain cancer cells to develop resistance to otherwise lethal therapies.
Dec 23, 2014
0
0
A new study by University of Kentucky researchers provides insight into developing new treatment strategies for basal-like breast cancer, commonly known as triple-negative breast cancer. This cancer is associated with early ...
Mar 14, 2012
0
0
In a study that could explain why some breast cancers are more aggressive than others, researchers say they now understand how cancer cells force normal cells to act like viruses - allowing tumors to grow, resist treatment, ...
Jul 13, 2017
1
177
The outside of a cancer cell is bombarded by signals. They come from the immune system, supporting tissues and other structures. But how do those signals impact cancer?
May 11, 2018
0
49
Researchers at Albert Einstein College of Medicine of Yeshiva University have identified a key player in the spread of breast cancer. The findings, published today in the online edition of Nature, identify a critical molecule ...
Jun 8, 2011
2
1
Cardamonin—a natural compound found in the spice cardamom and other plants—could have therapeutic potential for triple-negative breast cancer, according to a new study using human cancer cells. The findings also show ...
Apr 3, 2022
0
32
Immunotherapies for cancer—treatments that prime the immune system to attack tumors—are valuable weapons in the anti-cancer arsenal. But some cancers are more difficult to target with this strategy than others. Today, ...
Aug 17, 2020
0
478
New research from the UVA Cancer Center could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon and triple-negative breast cancer, that ultimately failed in human clinical trials.
Apr 6, 2021
0
111
Researchers at the University of Zurich and from IBM Research have investigated the varying composition of cancer and immune cells in over 100 breast tumors. They've found that aggressive tumors are often dominated by a single ...
Apr 16, 2019
0
48
Scientists from the Friedrich Miescher Institute for Biomedical Research have shown that a mutation in the lipid kinase PI3K, which occurs in about 30% of human breast cancers, itself evokes different forms of breast cancer. ...
Jul 12, 2011
0
0